GP episodes | Hospitalisations | Deaths | ||||
---|---|---|---|---|---|---|
Episodes/100,000 population (range) | N | Hospitalisations/100,000 population (range) | N | Deaths/100,000 population (range) | N | |
Respiratory disease | 1946 (1400–2267) | 175,070 | 156 (119–192) | 14,039 | 88 (64–119) | 7,915 |
Low risk | 1335 (963–1560) | 120,123 | 60 (46–74) | 5,380 | 60 (41–84) | 5,425 |
High risk | 2697 (1864–3189) | 242,616 | 265 (194–314) | 23,872 | 121 (97–156) | 10,915 |
Acute upper respiratory disease | 544 (420–681) | 48,900 | - | - | - | - |
Low risk | 457 (349–566) | 41,150 | - | - | - | - |
High risk | 644 (492–798) | 57,961 | - | - | - | - |
Pneumonia and Influenza | 154 (88–219) | 13,814 | 49 (32–66) | 4,367 | 66 (47–89) | 5,894 |
Low risk | 109 (63–153) | 9,807 | 28 (21–37) | 2,559 | 53 (37–72) | 4,729 |
High risk | 211 (115–312) | 19,025 | 70 (47–95) | 6,322 | 81 (62–107) | 7,307 |
Bronchitis/ Bronchiolitis | 1328 (954–1545) | 119,449 | 46 (34–55) | 4,114 | 3 (2–4) | 277 |
Low risk | 849 (597–984) | 76,385 | 30 (22–36) | 2,683 | 1 (0–1) | 75 |
High risk | 1908 (1336–2221) | 171,650 | 64 (46–75) | 5,749 | 6 (4–7) | 520 |
COPD | 110 (59–166) | 9,921 | 59 (43–70) | 5,352 | 24 (19–30) | 2,187 |
Low risk | 0 (0–0) | 2 | 0 (0–0) | 0 | 0 (0–0) | 0 |
High risk | 259 (123–420) | 23,306 | 127 (88–153) | 11,464 | 53 (39–63) | 4,807 |
Cardiorespiratory | - | - | 112 (81–131) | 10,086 | 113 (90–145) | 10,147 |
Low risk | - | - | 55 (43–69) | 4,990 | 60 (40–83) | 5,365 |
High risk | - | - | 177 (117–229) | 15,964 | 177 (129–209) | 15,909 |